Atara Files BLA for Tab-cel, Sets PDUFA Date for March 2027
Atara Biotherapeutics submitted the BLA for tabelecleucel, setting a March 31, 2027 FDA action date. If approved, the company would unlock a $31 million milestone payment from Pierre Fabre.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed